| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $158K | +426.7% |
| SG&A Expense | $998K | -25.6% |
| Operating Income | -$1.2M | +15.7% |
| Interest Expense | $588K | -23.5% |
| Pre-tax Income | -$1.7M | +31.4% |
| Income Tax | $0 | — |
| Net Income | -$1.7M | +31.4% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $61K | +3619.2% |
| Current Assets | $61K | +371.2% |
| Total Assets | $61K | +371.2% |
| Current Liabilities | $9.9M | +12.3% |
| Total Liabilities | $9.9M | +12.3% |
| Stockholders' Equity | -$9.9M | -11.8% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$792K | -15.4% |
| Investing Cash Flow | -$25K | +0.0% |
| Financing Cash Flow | $851K | +22.1% |